68Ga-PSMA PET in the Prostate Cancer

  • End date
    Dec 31, 2023
  • participants needed
  • sponsor
    Xijing Hospital
Updated on 30 July 2021
Yanyan Jia
Primary Contact
Xijing Hospital (5.0 mi away) Contact
radical prostatectomy


Efficacy of 68Ga PSMA PET / CT in the diagnosis of lymph node metastasis in patients with prostate cancer: a single center prospective randomized controlled trial.

To identify and compare the diagnostic efficacy of 68Ga-PSMA PET/CT and mpMRI for lymph nodes in patients with newly diagnosed prostate cancer.

Condition Brain Metastases, prostate tumors, metastases, Prostate Cancer, Early, Recurrent, secondary cancer, Metastasis, secondaries, Bone Metastases, Prostate Disorders, Malignant neoplasm of prostate, Liver Metastases, Prostatic disorder, metastatic disease, metastasized, PSMA-PET, metastatic tumor, Neoplasm Metastasis, prostate tumor, Prostate Cancer, Metastatic Cancer
Treatment PSMA PET
Clinical Study IdentifierNCT04967001
SponsorXijing Hospital
Last Modified on30 July 2021


Yes No Not Sure

Inclusion Criteria

High risk localized/locally advanced prostate cancer patients who are candidates for radical prostatectomy plus bilateral extended PLND; ISUP Gleason grade group 4

Exclusion Criteria

Prior history of any other cancer the last 5 years excluding basal cell carcinoma Proven metastases in bones or other distant metastases General contra-indications for MRI (pacemaker, aneurysm clips, any form of metal in the body, severe claustrophobia) Serious concomitant systemic disorders that in the opinion of the investigator would compromise the patient's ability to complete the study or interfere with the evaluation of the efficacy and safety of the study objectives Metal implants in the pelvic region which will deteriorate PET/MR/CT image quality
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note